首页> 美国卫生研究院文献>Malaria Journal >Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent associated factors challenges and solutions to reporting

【2h】

Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent associated factors challenges and solutions to reporting

机译：怀疑或证实治疗性的药物的药物可染色体的基于蒿属素的联合疗法：报告的程度相关因素挑战和解决方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Demographic and professional characteristics of 685 healthcare professionals, Uganda, 2018

机译：685个医疗保健专业人员的人口和专业特征，乌干达，2018年

著录项

期刊名称 Malaria Journal
作者
Ronald Kiguba; Helen Byomire Ndagije; Victoria Nambasa; Leonard Manirakiza; Elijah Kirabira; Allan Serwanga; Sten Olsson; Niko Speybroeck; Jackson Mukonzo;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类寄生动物、寄生虫学;医学寄生虫学;
关键词

机译：蒿属植物的组合疗法;治疗性低尼度;治疗性无效;治疗效果;治疗效果;药物检测;报告阿尔米斯蛋白的组合治疗衰竭;医疗专业人士;

相似文献

外文文献
中文文献
专利

1. Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso [J] . Toussaint Rouamba, Paul Sondo, Karim Derra, Drug Design, Development and Therapy . 2020,第1期

机译：加强亚撒拉南非亚撒哈拉非洲药物检测的最佳方法和策略：纳米龙及人口监测系统中一线蒿属素组合疗法治疗的患者队列研究，布基纳法索
2. P327: A situational analysis of pharmacovigilance in republic of benin based on the Artemisinin-based Combination Therapies (ACTs) [J] . A Aurel Constant, N Jude, M Achille, Antimicrobial Resistance and Infection Control . 2013,第SUPPLEMENTa1期

机译：P327：基于青蒿素的联合疗法（ACT）对贝宁共和国的药物警戒进行了情境分析
3. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial [J] . The Lancet . 2020,第10233期

机译：基于青蒿素的组合疗法与基于青蒿素的组合疗法，用于简单的疟原虫疟疾：多期，开放标签，随机临床试验
4. Combination of nitric oxide therapy, anti-oxidative therapy, low level laser therapy, plasma rich platelet therapy and stem cell therapy as a novel therapeutic application to manage the pain and treat many clinical conditions [C] . Salaheldin Halasa, Eva Dickinson Mechanisms for low-light therapy IX . 2014

机译：一氧化氮治疗，抗氧化治疗，低水平激光治疗，富含血浆的血小板治疗和干细胞治疗相结合，是一种新颖的治疗疼痛和多种临床疾病的治疗方法
5. Factors influencing the extent of accounting disclosures made in the annual reports of publicly reporting Australian not-for-profit organisations [D] . Ghoorah, Ushi. 2017

机译：公开报告澳大利亚非营利组织的年度报告中影响会计披露程度的因素
6. Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System Burkina Faso [O] . Toussaint Rouamba, Paul Sondo, Karim Derra, 2020

机译：加强撒哈拉以南非洲地区药物警戒的最佳途径和策略：一项在布基纳法索纳米罗健康与人口监测系统中使用基于青蒿素一线联合疗法治疗的患者的队列研究
7. Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapies: extent, associated factors, challenges and solutions to reporting [O] . Ronald Kiguba, Helen Byomire Ndagije, Victoria Nambasa, 2020

机译：怀疑或确认的蒿属植物的组合疗法的药物病因或证实的治疗性无效：报告的程度，相关因素，挑战和解决方案

Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent associated factors challenges and solutions to reporting

摘要

著录项

相似文献

相关主题

期刊订阅